Abstract
Human gut microbiota exists in a complicated symbiotic relationship which postulates to impact health and disease conditions on the host. Interestingly, the gut microbiome shows different mechanisms to regulate host physiology and metabolism including cell-to-cell communications. But microbiota imbalance is characterized to change in the host normal functioning and lead to the development and progression of major human diseases. Therefore, the direct cross talk through the microbial metabolites or peptides suggests the evidence of host health and disease. Recent reports highlight the adaptation signals/small molecules promoting microbial colonization which allows modulating immunity of host and leads to pathogen colonization. Moreover, quorum sensing peptides are also evident in the involvement of host disease conditions. Here, we review the current understanding of the gut microbiota cross talk with mammalian cells through metabolites and peptides. These studies are providing insight into the prediction of signature molecules which significantly provide information for the understanding of the interaction for precision medicine applications.
Similar content being viewed by others
References
Agus A, Massier S, Darfeuille-Michaud A et al (2014) Understanding host-adherent-invasive Escherichia coli INTERACTION IN Crohn’s disease: opening up new therapeutic strategies. Biomed Res Int:2014. https://doi.org/10.1155/2014/567929
Aoki R, Tsuchida S, Arai Y et al (2016) Effect of Bifidobacterium animalis subsp. lactis GCL2505 on the physiological function of intestine in a rat model. Food Sci Nutr 4:782–790. https://doi.org/10.1002/fsn3.344
Are A, Aronsson L, Wang S et al (2008) Enterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells. Proc Natl Acad Sci U S A 105:1943–1948. https://doi.org/10.1073/pnas.0711734105
Bailey MT, Dowd SE, Galley JD et al (2011) Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun 25:397–407. https://doi.org/10.1016/j.bbi.2010.10.023
Belkaid Y, Hand T (2014) Role of the microbiota in immunity and inflammation. Cell 157:121–141. https://doi.org/10.1016/j.cell.2014.03.011
Braga RM, Dourado MN, Araújo WL (2016) Microbial interactions: ecology in a molecular perspective. Braz J Microbiol 47:86–98. https://doi.org/10.1016/j.bjm.2016.10.005
Bruggemann H, Baumer S, Fricke WF et al (2003) The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc Natl Acad Sci U S A 100:1316–1321. https://doi.org/10.1073/pnas.0335853100
Carding S, Verbeke K, Vipond DT et al (2015) Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 26. https://doi.org/10.3402/mehd.v26.26191
Castaner O, Goday A, Park Y-M et al (2018) The gut microbiome profile in obesity: a systematic review. Int J Endocrinol 2018:4095789. https://doi.org/10.1155/2018/4095789
Castellarin M, Warren RL, Freeman JD et al (2012) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22:299–306. https://doi.org/10.1101/gr.126516.111
Chudnovskiy A, Mortha A, Kana V et al (2016) Host-protozoan interactions protect from mucosal infections through activation of the inflammasome. Cell 167:444–456.e14. https://doi.org/10.1016/j.cell.2016.08.076
Clarke SF, Murphy EF, Nilaweera K et al (2012) The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes 3:186–202. https://doi.org/10.4161/gmic.20168
Cunliffe RN, Mahida YR (2004) Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J Leukoc Biol 75:49–58. https://doi.org/10.1189/jlb.0503249
D’Argenio V, Salvatore F (2015) The role of the gut microbiome in the healthy adult status. Clin Chim Acta 451:97–102. https://doi.org/10.1016/j.cca.2015.01.003
David LA, Maurice CF, Carmody RN et al (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:559–563. https://doi.org/10.1038/nature12820
Davis CD (2016) The gut microbiome and its role in obesity. Nutr Today 51:167–174. https://doi.org/10.1097/NT.0000000000000167
De Vadder F, Kovatcheva-Datchary P, Goncalves D et al (2014) Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156:84–96. https://doi.org/10.1016/j.cell.2013.12.016
DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E (2016) Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis 22:1137–1150. https://doi.org/10.1097/MIB.0000000000000750
den Besten G, van Eunen K, Groen AK et al (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54:2325–2340. https://doi.org/10.1194/jlr.R036012
Dominguez-Bello MG, Godoy-Vitorino F, Knight R, Blaser MJ (2019) Role of the microbiome in human development. Gut 68:1108–1114. https://doi.org/10.1136/gutjnl-2018-317503
Duboc H, Rajca S, Rainteau D et al (2013) Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 62:531–539. https://doi.org/10.1136/gutjnl-2012-302578
Dürre P, Hollergschwandner C (2004) Initiation of endospore formation in Clostridium acetobutylicum. Anaerobe 10:69–74. https://doi.org/10.1016/j.anaerobe.2003.11.001
Foster JA, McVey Neufeld K-A (2013) Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36:305–312. https://doi.org/10.1016/j.tins.2013.01.005
Frank DN, Amand ALS, Feldman RA et al (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104:13780. https://doi.org/10.1073/pnas.0706625104
Franzosa EA, Sirota-Madi A, Avila-Pacheco J et al (2019) Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol 4:293–305. https://doi.org/10.1038/s41564-018-0306-4
Gaida MM, Mayer C, Dapunt U et al (2016) Expression of the bitter receptor T2R38 in pancreatic cancer: localization in lipid droplets and activation by a bacteria-derived quorum-sensing molecule. Oncotarget 7:12623–12632. https://doi.org/10.18632/oncotarget.7206
Gao J, Xu K, Liu H et al (2018) Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect Microbiol 8:13. https://doi.org/10.3389/fcimb.2018.00013
Gong J, Noel S, Pluznick JL et al (2019) Gut microbiota-kidney cross-talk in acute kidney injury. Semin Nephrol 39:107–116. https://doi.org/10.1016/j.semnephrol.2018.10.009
Hase K, Eckmann L, Leopard JD et al (2002) Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 70:953–963. https://doi.org/10.1128/iai.70.2.953-963.2002
Hildebrandt MA, Hoffmann C, Sherrill-Mix SA et al (2009) High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137:1716–1724.e1–2. https://doi.org/10.1053/j.gastro.2009.08.042
Hold GL, Smith M, Grange C et al (2014) Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol: WJG 20:1192–1210. https://doi.org/10.3748/wjg.v20.i5.1192
Hsiao WWL, Metz C, Singh DP, Roth J (2008) The microbes of the intestine: an introduction to their metabolic and signaling capabilities. Endocrinol Metab Clin N Am 37:857–871. https://doi.org/10.1016/j.ecl.2008.08.006
Jelsbak L, Thomsen LE, Wallrodt I et al (2012) Polyamines are required for virulence in Salmonella enterica Serovar typhimurium. PLoS One 7:e36149. https://doi.org/10.1371/journal.pone.0036149
Ji Y, Guo Q, Yin Y et al (2018) Dietary proline supplementation alters colonic luminal microbiota and bacterial metabolite composition between days 45 and 70 of pregnancy in Huanjiang mini-pigs. J Anim Sci Biotechnol 9:18. https://doi.org/10.1186/s40104-018-0233-5
Johnson KV-A (2020) Gut microbiome composition and diversity are related to human personality traits. Hum Microbiome J 15:100069. https://doi.org/10.1016/j.humic.2019.100069
Joossens M, Huys G, Cnockaert M et al (2011) Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut 60:631–637. https://doi.org/10.1136/gut.2010.223263
Kaper JB, Sperandio V (2005) Bacterial cell-to-cell signaling in the gastrointestinal tract. Infect Immun 73:3197–3209. https://doi.org/10.1128/IAI.73.6.3197-3209.2005
Kelly D, Campbell JI, King TP et al (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5:104–112. https://doi.org/10.1038/ni1018
Khan CMA (2014) The dynamic interactions between Salmonella and the microbiota, within the challenging niche of the gastrointestinal tract. In: Int. Sch. Res. Not. https://www.hindawi.com/journals/isrn/2014/846049/. Accessed 30 Jun 2020
Kiss EA, Vonarbourg C, Kopfmann S et al (2011) Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334:1561–1565. https://doi.org/10.1126/science.1214914
Knox NC, Forbes JD, Van Domselaar G, Bernstein CN (2019) The gut microbiome as a target for IBD treatment: are we there yet? Curr Treat Options Gastroenterol 17:115–126. https://doi.org/10.1007/s11938-019-00221-w
Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F (2016) From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165:1332–1345. https://doi.org/10.1016/j.cell.2016.05.041
Kumar S, Kolodkin-Gal I, Engelberg-Kulka H (2013) Novel quorum-sensing peptides mediating interspecies bacterial cell death. mBio 4:e00313–e00314. https://doi.org/10.1128/mBio.00314-13
Kyriachenko Y, Falalyeyeva T, Korotkyi O et al (2019) Crosstalk between gut microbiota and antidiabetic drug action. World J Diabetes 10:154–168. https://doi.org/10.4239/wjd.v10.i3.154
Lee JS, Cella M, McDonald KG et al (2011) AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat Immunol 13:144–151. https://doi.org/10.1038/ni.2187
Levy M, Thaiss CA, Elinav E (2016) Metabolites: messengers between the microbiota and the immune system. Genes Dev 30:1589–1597. https://doi.org/10.1101/gad.284091.116
Li J, Butcher J, Mack D, Stintzi A (2015) Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 21:139–153. https://doi.org/10.1097/MIB.0000000000000215
Liu J, Fu Y, Zhang H et al (2017) The hepatoprotective effect of the probiotic Clostridium butyricum against carbon tetrachloride-induced acute liver damage in mice. Food Funct 8:4042–4052. https://doi.org/10.1039/c7fo00355b
Loke P, Lim YAL (2016) A commensal protozoan strikes a balance in the gut. Cell Host Microbe 20:417–419. https://doi.org/10.1016/j.chom.2016.09.016
Lozupone CA, Stombaugh JI, Gordon JI et al (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489:220–230. https://doi.org/10.1038/nature11550
Lustri BC, Sperandio V, Moreira CG (2017) Bacterial chat: intestinal metabolites and signals in host-microbiota-pathogen interactions. Infect Immun 85:e00476–e00417. https://doi.org/10.1128/IAI.00476-17
Madan JC, Koestler DC, Stanton BA et al (2012) Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. mBio:3. https://doi.org/10.1128/mBio.00251-12
Maier L, Pruteanu M, Kuhn M et al (2018) Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555:623–628. https://doi.org/10.1038/nature25979
Marinelli L, Martin-Gallausiaux C, Bourhis J-M et al (2019) Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cells. Sci Rep 9:643. https://doi.org/10.1038/s41598-018-37019-2
Maukonen J, Saarela M (2015) Human gut microbiota: does diet matter? Proc Nutr Soc 74:23–36. https://doi.org/10.1017/S0029665114000688
Methé BA, Nelson KE, Pop M et al (2012) A framework for human microbiome research. Nature 486:215–221. https://doi.org/10.1038/nature11209
Mitsumori M, Xu L, Kajikawa H et al (2003) Possible quorum sensing in the rumen microbial community: detection of quorum-sensing signal molecules from rumen bacteria. FEMS Microbiol Lett 219:47–52. https://doi.org/10.1016/S0378-1097(02)01192-8
Moreira CG, Sperandio V (2016) The epinephrine/norepinephrine/autoinducer-3 interkingdom signaling system in Escherichia coli O157:H7. Adv Exp Med Biol 874:247–261. https://doi.org/10.1007/978-3-319-20215-0_12
Murray IA, Perdew GH (2017) Ligand activation of the Ah receptor contributes to gastrointestinal homeostasis. Curr Opin Toxicol 2:15–23. https://doi.org/10.1016/j.cotox.2017.01.003
Natividad JM, Agus A, Planchais J et al (2018) Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome. Cell Metab 28:737–749.e4. https://doi.org/10.1016/j.cmet.2018.07.001
Ng W-L, Bassler BL (2009) Bacterial quorum-sensing network architectures. Annu Rev Genet 43:197–222. https://doi.org/10.1146/annurev-genet-102108-134304
Ogilvie LA, Jones BV (2012) Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease? Gut 61:1642–1643. https://doi.org/10.1136/gutjnl-2012-302137
Pagliari D, Piccirillo CA, Larbi A, Cianci R (2015, 2015) The interactions between innate immunity and microbiota in gastrointestinal diseases. J Immunol Res. https://doi.org/10.1155/2015/898297
Perez-Pascual D, Monnet V, Gardan R (2016) Bacterial cell–cell communication in the host via RRNPP peptide-binding regulators. Front Microbiol 7. https://doi.org/10.3389/fmicb.2016.00706
Qin J, Li R, Raes J et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65. https://doi.org/10.1038/nature08821
Ramanan D, Tang MS, Bowcutt R et al (2014) Bacterial sensor Nod2 prevents small intestinal inflammation by restricting the expansion of the commensal Bacteroides vulgatus. Immunity 41:311–324. https://doi.org/10.1016/j.immuni.2014.06.015
Ramos-Molina B, Queipo-Ortuño MI, Lambertos A et al (2019) Dietary and gut microbiota polyamines in obesity- and age-related diseases. Front Nutr:6. https://doi.org/10.3389/fnut.2019.00024
Reichardt N, Duncan SH, Young P et al (2014) Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J 8:1323–1335. https://doi.org/10.1038/ismej.2014.14
Romani L, Zelante T, Luca AD et al (2014) Microbiota control of a tryptophan–AhR pathway in disease tolerance to fungi. Eur J Immunol 44:3192–3200. https://doi.org/10.1002/eji.201344406
Rooks MG, Garrett WS (2016) Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16:341–352. https://doi.org/10.1038/nri.2016.42
Rowland I, Gibson G, Heinken A et al (2018) Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr 57:1–24. https://doi.org/10.1007/s00394-017-1445-8
Rutherford ST, Bassler BL (2012) Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med 2. https://doi.org/10.1101/cshperspect.a012427
Sender R, Fuchs S, Milo R (2016) Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 14:e1002533. https://doi.org/10.1371/journal.pbio.1002533
Shastry RP, Aman M (2019) Rapid characterization of quorum sensing inhibitory molecules from Garcinia indica choisy seed methanol extract by GC-MS analysis. Curr Bioact Compd 5:1–5. https://doi.org/10.2174/1573407215666190408120140
Shastry RP, Arunrenganathan RR, Rai VR (2020) Molecular characterization of enterocin EF35 against human pathogens and its in-silico analysis against human cancer proteins TOP1 and PI3K. Biocatal Agric Biotechnol 23:101485. https://doi.org/10.1016/j.bcab.2019.101485
Shetty SA, Marathe NP, Shouche YS (2013) Opportunities and challenges for gut microbiome studies in the Indian population. Microbiome 1:24. https://doi.org/10.1186/2049-2618-1-24
Shibata N, Kunisawa J, Kiyono H (2017) Dietary and microbial metabolites in the regulation of host immunity. Front Microbiol 8. https://doi.org/10.3389/fmicb.2017.02171
Song SJ, Lauber C, Costello EK et al (2013) Cohabiting family members share microbiota with one another and with their dogs. eLife 2:e00458. https://doi.org/10.7554/eLife.00458
Spiegeleer BD, Verbeke F, D’Hondt M et al (2015) The quorum sensing peptides PhrG, CSP and EDF promote angiogenesis and invasion of breast cancer cells in vitro. PLoS One 10:e0119471. https://doi.org/10.1371/journal.pone.0119471
Sun J, Kato I (2016) Gut microbiota, inflammation and colorectal cancer. Genes Dis 3:130–143. https://doi.org/10.1016/j.gendis.2016.03.004
Sun L, Ma L, Ma Y et al (2018) Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectives. Protein Cell 9:397–403. https://doi.org/10.1007/s13238-018-0546-3
Tang WHW, Kitai T, Hazen SL (2017) Gut microbiota in cardiovascular health and disease. Circ Res 120:1183–1196. https://doi.org/10.1161/CIRCRESAHA.117.309715
Thomas S, Izard J, Walsh E et al (2017) The host microbiome regulates and maintains human health: a primer and perspective for non-microbiologists. Cancer Res 77:1783–1812. https://doi.org/10.1158/0008-5472.CAN-16-2929
Thompson JA, Oliveira RA, Djukovic A et al (2015) Manipulation of the quorum sensing signal AI-2 affects the antibiotic-treated gut microbiota. Cell Rep 10:1861–1871. https://doi.org/10.1016/j.celrep.2015.02.049
Thompson JA, Oliveira RA, Xavier KB (2016) Chemical conversations in the gut microbiota. Gut Microbes 7:163–170. https://doi.org/10.1080/19490976.2016.1145374
Tidjani AM, Lagier J-C, Raoult D (2016) Diet influence on the gut microbiota and dysbiosis related to nutritional disorders. Hum Microbiome J 1:3–11. https://doi.org/10.1016/j.humic.2016.09.001
Tofalo R, Cocchi S, Suzzi G (2019) Polyamines and gut microbiota. Front Nutr 6. https://doi.org/10.3389/fnut.2019.00016
Treem WR, Ahsan N, Shoup M, Hyams JS (1994) Fecal short-chain fatty acids in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 18:159–164. https://doi.org/10.1097/00005176-199402000-00007
Tuomainen M, Lindström J, Lehtonen M et al (2018) Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals. Nutr Diabetes 8. https://doi.org/10.1038/s41387-018-0046-9
Valdes AM, Walter J, Segal E, Spector TD (2018) Role of the gut microbiota in nutrition and health. BMJ 361. https://doi.org/10.1136/bmj.k2179
Velasquez MT, Ramezani A, Manal A, Raj DS (2016) Trimethylamine N-oxide: the good, the bad and the unknown. Toxins 8. https://doi.org/10.3390/toxins8110326
Velly H, Britton RA, Preidis GA (2017) Mechanisms of cross-talk between the diet, the intestinal microbiome, and the undernourished host. Gut Microbes 8:98–112. https://doi.org/10.1080/19490976.2016.1267888
Verbeke F, De Craemer S, Debunne N et al (2017) Peptides as quorum sensing molecules: measurement techniques and obtained levels in vitro and in vivo. Front Neurosci:11. https://doi.org/10.3389/fnins.2017.00183
Vich Vila A, Collij V, Sanna S et al (2020) Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun 11. https://doi.org/10.1038/s41467-019-14177-z
Vivarelli S, Salemi R, Candido S et al (2019) Gut microbiota and cancer: from pathogenesis to therapy. Cancers 11. https://doi.org/10.3390/cancers11010038
Wang Y, Kasper LH (2014) The role of microbiome in central nervous system disorders. Brain Behav Immun 38:1–12. https://doi.org/10.1016/j.bbi.2013.12.015
Wang H, Naghavi M, Allen C et al (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1459–1544. https://doi.org/10.1016/S0140-6736(16)31012-1
Wilson Tang WH, Hazen SL (2017) The gut microbiome and its role in cardiovascular diseases. Circulation 135:1008–1010. https://doi.org/10.1161/CIRCULATIONAHA.116.024251
Wu H, Esteve E, Tremaroli V et al (2017) Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med 23:850–858. https://doi.org/10.1038/nm.4345
Wynendaele E, Verbeke F, D’Hondt M et al (2015a) Crosstalk between the microbiome and cancer cells by quorum sensing peptides. Peptides 64:40–48. https://doi.org/10.1016/j.peptides.2014.12.009
Wynendaele E, Verbeke F, Stalmans S et al (2015b) Quorum sensing peptides selectively penetrate the blood-brain barrier. PLoS One 10:e0142071. https://doi.org/10.1371/journal.pone.0142071
Zelante T, Iannitti RG, Cunha C et al (2013) Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39:372–385. https://doi.org/10.1016/j.immuni.2013.08.003
Zhang LS, Davies SS (2016) Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med 8. https://doi.org/10.1186/s13073-016-0296-x
Zhang X, Zhao Y, Xu J et al (2015) Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Sci Rep 5:14405. https://doi.org/10.1038/srep14405
Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30:492–506. https://doi.org/10.1038/s41422-020-0332-7
Zou S, Fang L, Lee M-H (2018) Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterol Rep 6:1–12. https://doi.org/10.1093/gastro/gox031
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shastry, R.P., Rekha, P.D. Bacterial cross talk with gut microbiome and its implications: a short review. Folia Microbiol 66, 15–24 (2021). https://doi.org/10.1007/s12223-020-00821-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-020-00821-5